BIBW2992 DiMaleate （850140-73-7）

Min.Order / FOB Price:Get Latest Price

10 Gram	Negotiable

10 Gram

Negotiable

Min.Order :10 Gram
Purity: 99%
Payment Terms : L/C,T/T,

Keywords

BIBW2992 DiMaleate 99% BIBW2992 DiMaleate BIBW2992 DiMaleate Manufacturer

Quick Details

Appearance:white solid
Application:Afatinib dimaleate (Tovok; BIBW2992; Gilotrif) is a salt form of Afatinib. Afatinib is a second-generation, orally administered, irreversible inhibitor of the ErbB family of tyrosine kinases. ChEBI:
PackAge:As customer request
ProductionCapacity:100|Kilogram|Week
Storage:
Transportation:By Sea/Air/Courier

Superiority:

Triumph Chemical Title

Triumph Company Office picture

Triumph Company advantage

Triumph Testing title picture

Triumph Testing way

Welcome to contact us

Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details:

BIBW2992 DiMaleate

CAS:	850140-73-7
MF:	C32H33ClFN5O11
MW:	718.0827232
Appearance:	White solid
Assay:	99%
Description: Afatinib dimaleate (Tovok; BIBW2992; Gilotrif) is a salt form of Afatinib. Afatinib is a second-generation, orally administered, irreversible inhibitor of the ErbB family of tyrosine kinases.
Uses: A maleate salt obtained by combining afatinib with two molar equivalents of maleic acid. Used for the first-line treatment of patients with metastatic non-small cell lung cancer.

View All

Visit Store

BIBW2992 DiMaleate ...